Publications by authors named "Thomas Cacciarelli"

Claim this Profile
L
Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Obaid S Shaikh, Shari Rogal, Anam Malik, Vivek Sharma, Thomas Cacciarelli

Exp Clin Transplant· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Regression of Advanced Hepatocellular Carcinoma.
Dhiraj J Sonbare, Rupal Bandi, Vivek Sharma, Thomas Cacciarelli, Obaid S Shaikh

Case Rep Gastroenterol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem.
Nina Singh, Costi D Sifri, Fernanda P Silveira, Rachel Miller, Kevin S Gregg, Thomas V Cacciarelli

Med Mycol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.
Hsin-Yun Sun, Thomas V Cacciarelli, Nina Singh

Transplantation· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rifaximin use for hepatic encephalopathy on the risk of early post-transplant infections in liver transplant recipients.
Hsin-Yun Sun, Marilyn Wagener, Thomas V Cacciarelli, Nina Singh

Clin Transplant· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the duration of posttransplant renal replacement therapy on bacterial infections in liver transplant recipients.
Hsin-Yun Sun, Thomas V Cacciarelli, Marilyn M Wagener, Nina Singh

Liver Transpl· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying a targeted population at high risk for infections after liver transplantation in the MELD era.
Hsin-Yun Sun, Thomas V Cacciarelli, Nina Singh

Clin Transplant· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up.
Ashokkumar Jain, Ashish Singhal, Paulo Fontes, George Mazariegos, Michael E DeVera, Thomas Cacciarelli

Transplantation· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients.
Hsin-Yun Sun, Thomas V Cacciarelli, Marilyn M Wagener, Nina Singh

Transpl Immunol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretransplant cryptococcosis and outcome after liver transplantation.
Costi D Sifri, Hsin-Yun Sun, Thomas V Cacciarelli, Brian Wispelwey, Timothy L Pruett

Liver Transpl· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pretransplant infections on clinical outcomes of liver transplant recipients.
Hsin-Yun Sun, Thomas V Cacciarelli, Nina Singh

Liver Transpl· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated expression of T-helper cell responses and susceptibility to infections in high-risk liver transplant recipients.
Hsin-Yun Sun, Nina Singh, Thomas V Cacciarelli, Cheryl Wannstedt, Marilyn M Wagener

Transpl Immunol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protothecosis after liver transplantation.
Masashi Narita, Robert R Muder, Thomas V Cacciarelli, Nina Singh

Liver Transpl· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Debra Mayher, Lisa Tickerhoof, Thomas V Cacciarelli

Liver Transpl· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic iron content and the risk of Staphylococcus aureus bacteremia in liver transplant recipients.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Debra Mayher, Lisa Tickerhoof, Thomas V Cacciarelli

Prog Transplant· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
Jawad Ahmad, Kathy K Downey, Mohamed Akoad, Thomas V Cacciarelli

Liver Transpl· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
Jawad Ahmad, Cindy L Bryce, Thomas Cacciarelli, Mark S Roberts

Ann Intern Med· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative therapy use in liver transplant recipients.
Lisa Tickerhoof, Marilyn M Wagener, Thomas V Cacciarelli, Nina Singh

Prog Transplant· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive aspergillosis in the recipients of liver retransplantation.
Nina Singh, Timothy L Pruett, Sally Houston, Patricia Muñoz, Thomas V Cacciarelli

Liver Transpl· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients.
Nina Singh, Cheryl Squier, Cheryl Wannstedt, Lois Keyes, Marilyn M Wagener, Thomas V Cacciarelli

Infect Control Hosp Epidemiol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to liver transplantation: can we do a better job?
Thomas V Cacciarelli

Liver Transpl· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
Nina Singh, Cheryl Wannstedt, Lois Keyes, Marilyn M Wagener, Thomas V Cacciarelli

Liver Transpl· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Marilyn M Wagener, Timothy Gayowski, Thomas V Cacciarelli

Transplantation· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease.
Nina Singh, Cheryl Wannstedt, Lois Keyes, Timothy Gayowski, Marilyn M Wagener, Thomas V Cacciarelli

Transplantation· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens.
Nina Singh, Marilyn M Wagener, Asia Obman, Thomas V Cacciarelli, Michael E de Vera

Liver Transpl· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis